Oct 21, 2020 | BioCity Group Ltd
BioCity, the pioneering life science incubator and business collective, supported by education charity Ignite! brought together ninety students from five Nottingham secondary schools, to celebrate the legacy of the celebrated Nottingham mathematician, Ada Lovelace, to...
Sep 24, 2020 | BioCity Group Ltd
Dr Richard Weaver, Founder & CEO of Xenogesis with Dr Simon Hirst, Founder & CEO of Sygnature Discovery Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has significantly expanded its DMPK capabilities and...
Apr 3, 2020 | BioCity Group Ltd, Member News
One of Nottingham’s most successful bioscience companies is working towards developing a drug to help treat the deadly coronavirus. Sygnature Discovery, which moved into BioCity in Nottingham city centre in 2004, provides drug discovery and pre-clinical services...
Dec 17, 2018 | BioCity Group Ltd, Member News
Fifty-one weeks of the year, the businesses based at BioCity are busy tackling global environmental and health challenges. But for one week only, they tackled a different type of challenge. The competition, organised by BioCity, asked companies to grow their own...
Oct 15, 2018 | BioCity Group Ltd, Member News
Forty-five girls who are students at three Nottingham high schools took part in an Ada Lovelace Day event at leading life sciences incubator, BioCity Nottingham, to learn about the opportunities of a career in Science, Technology, Engineering and Mathematics (STEM)....
Oct 1, 2018 | BioCity Group Ltd, Member News, Uncategorized
Image: Richard Weaver, XenoGesis Leading DMPK/ADME provider, XenoGesis has celebrated the official opening of its new laboratories and offices at BioCity Nottingham’s state-of-the-art Discovery Building. Founded in 2011 by Richard Weaver, XenoGesis is...
